Logo Medical Science Monitor

Call: +1.631.470.9640
Mon - Fri 10:00 am - 02:00 pm EST

Contact Us

Logo Medical Science Monitor Logo Medical Science Monitor Logo Medical Science Monitor

15 May 2002

Apolipoproteins A-1 and B and the likelihood of non-fatal stroke and myocardial infarction -- data from The Third National Health and Nutrition Examination Survey.

Wayne H Giles, Janet B Croft, Adnan I Qureshi, Lee R Guterman, L Nelson Hopkins

Med Sci Monit 2002; 8(5): CR311-316 :: ID: 420844

Abstract

BACKGROUND: The measurement of plasma apolipoproteins (APO) has been proposedfor predicting the risk of cardiovascular diseases. However, the association between APOs and strokeis not well defined. MATERIAL/METHODS: We evaluated the association between plasma concentrations ofAPO A-1 and APO B with a physician diagnosis of stroke (n=153), and electrocardiogram evidence or physiciandiagnosis of myocardial infarction (n=379), in a nationally representative sample of 3,696 US adultsaged >40 years who participated in the Third National Health and Nutrition Examination Survey. Multivariatelogistic regression analyses were used to investigate these relationships. RESULTS: After adjusting fordifferences in age, gender, race/ethnicity, education, hypertension, cholesterol, body mass index, andcigarette smoking, the upper quartile of APO A-1 (> or = 161 mg/dl) when compared with the lowest quartile( or = 1.59 when compared witha ratio < or = 1.04 was associated with a decreased likelihood of myocardial infarction (OR, 0.3; 95%CI, 0.2-0.6); and stroke (OR 0.4, 95% CI, 0.2-1.0). CONCLUSIONS: Higher APO A-1 concentrations were associatedwith a decreased likelihood for myocardial infarction but not for stroke. The APO A-1 to B ratio wasinversely associated with both myocardial infarction and stroke and may be an important protective clinicalmarker for atherosclerosis.

Keywords: Apolipoprotein A-I, Apolipoproteins B, Arteriosclerosis, Cerebrovascular Accident, Electrocardiography, Odds Ratio, Risk Factors

Add Comment 0 Comments

Editorial

01 May 2024 : Editorial  

Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)

Dinah V. Parums

DOI: 10.12659/MSM.944927

Med Sci Monit 2024; 30:e944927

In Press

16 Mar 2024 : Clinical Research  

Diagnostic Efficiency of ACR-TIRADS Score for Differentiating Benign and Malignant Thyroid Nodules of Vario...

Med Sci Monit In Press; DOI: 10.12659/MSM.943228  

0:00

08 May 2024 : Clinical Research  

Effect of Individualized PEEP Guided by Driving Pressure on Diaphragm Function in Patients Undergoing Lapar...

Med Sci Monit In Press; DOI: 10.12659/MSM.944022  

0:00

21 Mar 2024 : Clinical Research  

Impact of Serum Vitamin D, B6, and B12 and Cognitive Functions on Quality of Life in Peri- and Postmenopaus...

Med Sci Monit In Press; DOI: 10.12659/MSM.943249  

17 Mar 2024 : Clinical Research  

Protective Role of TRPC3 Gene Polymorphism (rs10518289) in Obstructive Sleep Apnea Hypopnea Syndrome Among ...

Med Sci Monit In Press; DOI: 10.12659/MSM.942667  

Most Viewed Current Articles

17 Jan 2024 : Review article  

Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron Variant

DOI :10.12659/MSM.942799

Med Sci Monit 2024; 30:e942799

0:00

14 Dec 2022 : Clinical Research  

Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase Levels

DOI :10.12659/MSM.937990

Med Sci Monit 2022; 28:e937990

0:00

16 May 2023 : Clinical Research  

Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...

DOI :10.12659/MSM.940387

Med Sci Monit 2023; 29:e940387

0:00

01 Jan 2022 : Editorial  

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...

DOI :10.12659/MSM.935952

Med Sci Monit 2022; 28:e935952

0:00

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Medical Science Monitor eISSN: 1643-3750
Medical Science Monitor eISSN: 1643-3750